# Effects of NLS-133, a Potential Non-Hormonal "On-Demand" Male Contraceptive

> **NCT07393334** · PHASE2 · RECRUITING · sponsor: **Next Life Sciences** · enrollment: 10 (estimated)

## Conditions studied

- Male Contraception
- Semen Volume
- Sperm Motility

## Interventions

- **DRUG:** NLS-133
- **DRUG:** Placebo
- **DRUG:** Active Comparator #1

## Key facts

- **NCT ID:** NCT07393334
- **Lead sponsor:** Next Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-02
- **Primary completion:** 2026-03
- **Final completion:** 2026-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07393334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07393334, "Effects of NLS-133, a Potential Non-Hormonal "On-Demand" Male Contraceptive". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07393334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*